Your browser doesn't support javascript.
loading
Psoralen-loaded polymeric lipid nanoparticles combined with paclitaxel for the treatment of triple-negative breast cancer.
Liu, Fengjie; Li, Lihong; Lan, Meng; Zou, Tengteng; Kong, Zhaodi; Cai, Tiange; Wu, Xiaoyu; Cai, Yu.
Affiliation
  • Liu F; College of Pharmacy, Jinan University, Guangzhou, Guangdong, 510632, PR China.
  • Li L; College of Pharmacy, Jinan University, Guangzhou, Guangdong, 510632, PR China.
  • Lan M; College of Pharmacy, Jinan University, Guangzhou, Guangdong, 510632, PR China.
  • Zou T; College of Pharmacy, Jinan University, Guangzhou, Guangdong, 510632, PR China.
  • Kong Z; College of Pharmacy, Jinan University, Guangzhou, Guangdong, 510632, PR China.
  • Cai T; College of Life Sciences, Liaoning University, Shenyang, 110036, PR China.
  • Wu X; Advanced Pharmaceutics & Drug Delivery Laboratory, Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College Street, Toronto, Ontario, Canada.
  • Cai Y; College of Pharmacy, Jinan University, Guangzhou, Guangdong, 510632, PR China.
Nanomedicine (Lond) ; 16(27): 2411-2430, 2021 11.
Article in En | MEDLINE | ID: mdl-34749510

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Paclitaxel / Nanoparticles / Triple Negative Breast Neoplasms Limits: Animals / Female / Humans Language: En Journal: Nanomedicine (Lond) Year: 2021 Document type: Article Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Paclitaxel / Nanoparticles / Triple Negative Breast Neoplasms Limits: Animals / Female / Humans Language: En Journal: Nanomedicine (Lond) Year: 2021 Document type: Article Country of publication: United kingdom